Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15679714rdf:typepubmed:Citationlld:pubmed
pubmed-article:15679714lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C0004096lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C0205476lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C0545082lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C1960048lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C0966225lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C2825096lld:lifeskim
pubmed-article:15679714lifeskim:mentionsumls-concept:C0175673lld:lifeskim
pubmed-article:15679714pubmed:issue3lld:pubmed
pubmed-article:15679714pubmed:dateCreated2005-1-31lld:pubmed
pubmed-article:15679714pubmed:abstractTextPatients with severe persistent asthma who are inadequately controlled despite treatment according to current asthma management guidelines have a significant unmet medical need. Such patients are at high risk of serious exacerbations and asthma-related mortality.lld:pubmed
pubmed-article:15679714pubmed:languageenglld:pubmed
pubmed-article:15679714pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15679714pubmed:citationSubsetIMlld:pubmed
pubmed-article:15679714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15679714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15679714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15679714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15679714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15679714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15679714pubmed:statusMEDLINElld:pubmed
pubmed-article:15679714pubmed:monthMarlld:pubmed
pubmed-article:15679714pubmed:issn0105-4538lld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:BousquetJJlld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:CabreraPPlld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:FoxHHlld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:BerkmanNNlld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:WenzelSSlld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:HolgateSSlld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:BACHR OROlld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:HedgecockSSlld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:CioppaG...lld:pubmed
pubmed-article:15679714pubmed:authorpubmed-author:BloggMMlld:pubmed
pubmed-article:15679714pubmed:issnTypePrintlld:pubmed
pubmed-article:15679714pubmed:volume60lld:pubmed
pubmed-article:15679714pubmed:ownerNLMlld:pubmed
pubmed-article:15679714pubmed:authorsCompleteYlld:pubmed
pubmed-article:15679714pubmed:pagination302-8lld:pubmed
pubmed-article:15679714pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:meshHeadingpubmed-meshheading:15679714...lld:pubmed
pubmed-article:15679714pubmed:year2005lld:pubmed
pubmed-article:15679714pubmed:articleTitleThe effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.lld:pubmed
pubmed-article:15679714pubmed:affiliationHôpital Arnaud de Villeneuve, Montpellier, France.lld:pubmed
pubmed-article:15679714pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15679714pubmed:publicationTypeMeta-Analysislld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15679714lld:pubmed